Letter by Campochiaro et al Regarding Article, "Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity"

Circulation. 2018 May 29;137(22):2421-2422. doi: 10.1161/CIRCULATIONAHA.117.033305.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiotoxicity*
  • Heart Diseases / immunology*
  • Humans
  • Immunologic Factors

Substances

  • Immunologic Factors